Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	13.28	5.38	8.49	11.78	24.06	14.24
Cash & Short-Term Investments	13.28	5.38	8.49	11.78	24.06	14.24
Cash Growth	105.07%	-36.61%	-27.93%	-51.03%	68.89%	105.42%
Prepaid Expenses	0.16	0.35	0.83	0.62	0.62	0.87
Restricted Cash	-	-	-	0.05	0.05	0.05
Total Current Assets	13.44	5.74	9.32	12.45	24.73	15.16
Property, Plant & Equipment	0	0	0.04	0.34	0.42	0.56
Other Long-Term Assets	-	-	0	0.02	0.03	0.02
Total Assets	13.44	5.74	9.36	12.81	25.17	15.74
Accounts Payable	0.43	0.25	0.66	0.78	0.28	0.73
Accrued Expenses	0.84	0.76	0.94	1.01	2.66	1.25
Current Portion of Leases	-	-	0.04	0.14	0.13	0.12
Other Current Liabilities	-	-	-	0.02	-	0.1
Total Current Liabilities	1.27	1.02	1.63	1.94	3.07	2.2
Long-Term Debt	-	-	-	-	-	0.23
Long-Term Leases	-	-	-	0.04	0.17	0.3
Total Liabilities	1.27	1.02	1.63	1.97	3.24	2.72
Common Stock	-	-	-	-	-	0
Additional Paid-In Capital	160.3	151.08	146.94	139.22	138.83	116.63
Retained Earnings	-148.13	-146.36	-139.21	-128.38	-116.9	-103.61
Total Common Equity	12.17	4.72	7.73	10.84	21.93	13.02
Shareholders' Equity	12.17	4.72	7.73	10.84	21.93	13.02
Total Liabilities & Equity	13.44	5.74	9.36	12.81	25.17	15.74
Total Debt	-	-	0.04	0.17	0.3	0.64
Net Cash (Debt)	13.28	5.38	8.46	11.61	23.76	13.6
Net Cash Growth	105.07%	-36.34%	-27.18%	-51.14%	74.69%	112.00%
Net Cash Per Share	18.46	6.83	36.52	91.94	200.01	320.24
Filing Date Shares Outstanding	4.8	4.78	0.51	0.13	0.13	0.13
Total Common Shares Outstanding	4.78	1.73	0.42	0.13	0.13	0.05
Working Capital	12.17	4.72	7.69	10.51	21.66	12.97
Book Value Per Share	2.55	2.72	18.57	85.64	175.00	243.18
Tangible Book Value	12.17	4.72	7.73	10.84	21.93	13.02
Tangible Book Value Per Share	2.55	2.72	18.57	85.64	175.00	243.18
Machinery	-	0.31	1.1	1.31	1.19	1.23
Leasehold Improvements	-	-	0.05	0.05	0.05	0.05

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q